Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

CTRI February 25, 2026

Centuri Holdings Fourth Quarter 2025 Earnings Call - Record Revenue, 1.5x Book-to-Bill and Backlog Surge to $5.9B

Centuri closed 2025 with record revenue, stronger base profitability and a meaningful backlog build that management says underpins 2026 guidance. The company reported $3.0 billion in revenue for the y...

  • Centuri delivered record 2025 revenue of $3.0 billion, with base revenue up 18% year over year and base gross profit up 35%.
  • Bookings exceeded $4.5 billion in 2025, producing a 1.5 times book-to-bill for the year, well above the 1.1 target.
  • Year-end backlog was approximately $5.9 billion, a 59% increase year over year, and management says it covers over 85% of 2026 base revenue guidance.
  • +17 more takeaways
EXLS February 25, 2026

EXL Service Holdings, Inc. Q4 2025 Earnings Call - Data and AI now 57% of revenue, powering outsized growth and large enterprise wins

EXL closed 2025 on clear momentum, led by a pivot to data and AI that now accounts for 57% of revenue and grew roughly 21% year over year in Q4. The company delivered a strong quarter and full year, b...

  • Q4 revenue was $542.6 million, up 12.7% year over year on a reported basis; full-year 2025 revenue was $2.09 billion, about 14% growth for the year.
  • Data and AI-led revenue grew roughly 20.7%-21% year over year in Q4 and now represents 57% of total revenue; digital operations is 43% and grew about 4% year over year.
  • Total operations revenue, combining data/AI-led operations and digital operations, grew 11% in Q4 and 14% for the full year.
  • +14 more takeaways
BXC February 25, 2026

BlueLinx Holdings Q4 and Full Year 2025 Earnings Call - Specialty Mix and Multifamily Growth Kept Sales Flat, Cash Strong Amid Soft Housing

BlueLinx reported resilient results in a weak housing market, delivering flat full-year net sales of $3.0 billion and $83 million of adjusted EBITDA while protecting margins through a deliberate shift...

  • Full-year 2025 net sales were $3.0 billion, essentially flat versus 2024, driven by volume gains and the Disdero acquisition offsetting price deflation.
  • Adjusted EBITDA for 2025 was $83 million and adjusted net income was $7.8 million, or $0.97 adjusted diluted EPS; GAAP net income was $219,000, or $0.02 diluted EPS.
  • Specialty products now represent roughly 70% of net sales and over 80% of gross profit, with specialty gross margin of 18.1% in Q4 and 18% for the year.
  • +11 more takeaways
TALO February 25, 2026

Talos Energy Fourth Quarter 2025 Earnings Call - $418M Adjusted FCF Powered Buybacks as Daenerys Appraisal and Monument Move Forward, Genovesa Shut-In a Near-Term Headwind

Talos closed 2025 with a clear message. Operational fixes and a revamped strategy translated into $1.2 billion of adjusted EBITDA and $418 million of adjusted free cash flow, allowing aggressive share...

  • Talos generated approximately $1.2 billion of adjusted EBITDA and $418 million of adjusted free cash flow in 2025 despite a weakening oil price environment.
  • The company returned about 44% of adjusted free cash flow to shareholders via share repurchases in 2025, reducing outstanding share count by roughly 7%.
  • Talos expects 2026 production of 85,000 to 90,000 boe/d, and 62,000 to 66,000 bbl/d of oil, with oil making up roughly 73% of volumes, improving margins.
  • +17 more takeaways
FSS February 25, 2026

Federal Signal Corporation Q4 2025 Earnings Call - Record 2025, 2026 guide aims higher with M&A and margin tailwinds

Federal Signal closed 2025 with record revenue, EBITDA, and adjusted EPS, and handed investors a 2026 guide that leans on recent M&A plus organic growth. Management pushed three themes hard, integrati...

  • 2025 was a record year, with net sales of $2.18 billion, adjusted EBITDA of $438.9 million (20.1% margin), and adjusted EPS of $4.23.
  • Q4 2025 revenue was $597 million, up 27% year over year; Q4 adjusted EBITDA was $119.4 million, up 34% and a 20% margin.
  • Orders for full-year 2025 were $2.22 billion, up 20% year over year; Q4 orders were $647 million, up 45% and including $132 million of acquired backlog from New Way.
  • +14 more takeaways
MGPI February 25, 2026

MGP Ingredients Fourth Quarter 2025 Earnings Call - Betting on Penelope and cost cuts to weather a down 2026

MGP delivered results slightly ahead of guidance for 2025, but management is explicit: 2026 will likely be another down year. The playbook is clear and deliberate, not flashy. Push premium plus brands...

  • Company message: 2026 expected to be another down year, but management is confident MGP can deliver sustained growth from the 2026 baseline via strategic focus and self-help actions.
  • 2025 full year results: consolidated sales $536 million, adjusted EBITDA $116 million, adjusted basic EPS $2.85. Q4 sales $138 million (down 23%), Q4 adjusted EBITDA $26 million, Q4 adjusted EPS $0.63.
  • Goodwill impairment: GAAP net loss of $135 million in Q4 primarily driven by a discrete non-cash $153 million adjustment to reduce carrying value of goodwill and certain indefinite-lived intangibles in Branded Spirits.
  • +12 more takeaways
GPOR February 25, 2026

Gulfport Energy Q4 2025 Earnings Call - Aggressive Q1 Buybacks Backed by Utica-Focused 2026 Plan and Rising Gas Realizations

Gulfport closed 2025 with strong cash generation and a clear playbook for 2026: lean into the highest-return Utica dry and wet gas windows, finish a $100 million discretionary acreage push, and use bo...

  • 2026 development concentrated in Utica dry gas and Utica wet gas windows, with >75% of 2026 turn-in-line weighted to those two areas.
  • Company guidance: total 2026 capital spend $400 million to $430 million, including $35 million to $40 million for maintenance, land, and seismic.
  • Gulfport plans to allocate more than $140 million to share repurchases in Q1 2026, funded by Adjusted Free Cash Flow and revolver capacity while targeting leverage at or below ~1x.
  • +11 more takeaways
SLRC February 25, 2026

SLR Investment Corp Q4 2025 Earnings Call - Shift to Asset-Based, Specialty Finance Drives Stable Returns and Lower Risk

SLR reported a steady quarter and a year that reads like a deliberate repositioning playbook. Management pushed the portfolio deeper into asset-based and specialty finance, booked strong origination a...

  • Q4 results: net investment income of $0.40 per share, net income of $0.46 per share, and NAV of $18.26 per share at December 31, 2025.
  • Annual performance: 2025 net income of $1.70 per share, a 9.3% return on average equity; management expects this to compare favorably to public and non-listed BDC peers.
  • Portfolio size and growth: comprehensive portfolio of $3.3 billion at year-end, up 7.2% year-over-year; originations of $462 million in Q4 and $1.84 billion for the full year, the second-highest quarterly originations on record.
  • +15 more takeaways
UWMC February 25, 2026

UWM Holdings Corporation Fourth Quarter and Full Year 2025 Earnings Call - Dominant origination growth, strategic push to bring servicing in-house and close Two Harbors deal

UWM reported a strong 2025 with originations up sharply and industry-leading rankings intact, but the headline numbers mask several structural moves and one-time hits. Originations totaled $163.4 bill...

  • UWM delivered $163.4 billion of originations in 2025, up 17% versus 2024, and $49.6 billion in Q4, up 28% year-over-year.
  • Company reported full-year net income of $244 million, down from $329 million in 2024, after a $435 million MSR write-down.
  • Q4 net income was $164.5 million and included a $28.8 million MSR write-down; adjusted EBITDA for Q4 was $232.8 million and over $697 million for the full year.
  • +12 more takeaways
MDLN February 25, 2026

Medline Industries Q4 2025 Earnings Call - $2.4B New Customer Signings Fuel Growth; IPO Strengthened Balance Sheet

Medline closed 2025 with broad-based top-line momentum, reporting $28.4 billion in sales, up 12% year over year, and a record $2.4 billion in total new customer signings. The year ended with a cleaner...

  • Total net sales 2025 were $28.4 billion, up 12% year over year, with organic growth of 11%.
  • Fourth quarter net sales were $7.8 billion, up 15% year over year; the quarter benefited from one additional business day.
  • Medline recorded $2.4 billion in total new customer signings in 2025, including Prime Vendor and non-Prime Vendor wins such as the U.S. Department of Veterans Affairs and a large faith-based IDN that consolidated five distributors.
  • +16 more takeaways